While the extant literature identifies the enhancement of lung fibrosis through MUC5B overexpression within the alveolar and distal bronchiolar compartments, our findings reveal that targeted overexpression within the proximal airways may impart protective advantages. Here, MUC5B is linked to pulmonary fibrosis.